Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons
Aromatic L-amino acid decarboxylase deficiency (AADC) is a rare neurodevelopmental disorder. Here the authors describe a clinical trial of MR-guided delivery of AAV2-AADC for the treatment of AADC.
Enregistré dans:
Auteurs principaux: | Toni S. Pearson, Nalin Gupta, Waldy San Sebastian, Jill Imamura-Ching, Amy Viehoever, Ana Grijalvo-Perez, Alex J. Fay, Neha Seth, Shannon M. Lundy, Youngho Seo, Miguel Pampaloni, Keith Hyland, Erin Smith, Gardenia de Oliveira Barbosa, Jill C. Heathcock, Amy Minnema, Russell Lonser, J. Bradley Elder, Jeffrey Leonard, Paul Larson, Krystof S. Bankiewicz |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/77c5fbe7e4b84dc5bdd76784b47254d0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
par: Anouke van Rumund, et autres
Publié: (2021) -
Spatial frequency sensitivity in macaque midbrain
par: Chih-Yang Chen, et autres
Publié: (2018) -
Visualizing the enzyme mechanism of mevalonate diphosphate decarboxylase
par: Chun-Liang Chen, et autres
Publié: (2020) -
Chemical modulation of the defensive behavior in the midbrain tectum
par: Brandão, M. L.; Anseloni, V. Z.; Pandóssio, J. E.; Araújo, J.; Castilho, V. M.
Publié: (1999) -
Pyrazinamide triggers degradation of its target aspartate decarboxylase
par: Pooja Gopal, et autres
Publié: (2020)